TD Asset Management Inc. reduced its holdings in Clorox Co (NYSE:CLX) by 14.8% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 270,397 shares of the company’s stock after selling 46,970 shares during the period. TD Asset Management Inc.’s holdings in Clorox were worth $56,829,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of CLX. Marshall Wace North America L.P. purchased a new position in shares of Clorox in the 1st quarter worth $65,000. Morgan Stanley grew its stake in shares of Clorox by 8.4% in the 1st quarter. Morgan Stanley now owns 733,303 shares of the company’s stock worth $127,046,000 after buying an additional 56,933 shares in the last quarter. Capital Investment Advisors LLC purchased a new position in shares of Clorox in the 2nd quarter worth $218,000. Assenagon Asset Management S.A. purchased a new position in shares of Clorox in the 2nd quarter worth $5,001,000. Finally, New York State Teachers Retirement System grew its stake in shares of Clorox by 7.1% in the 2nd quarter. New York State Teachers Retirement System now owns 180,340 shares of the company’s stock worth $39,561,000 after buying an additional 11,975 shares in the last quarter. 75.81% of the stock is owned by institutional investors and hedge funds.
In other news, EVP Laura Stein sold 8,570 shares of the business’s stock in a transaction dated Tuesday, November 3rd. The shares were sold at an average price of $212.19, for a total value of $1,818,468.30. Following the completion of the sale, the executive vice president now owns 59,755 shares in the company, valued at approximately $12,679,413.45. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP William S. Bailey sold 15,114 shares of the business’s stock in a transaction dated Tuesday, November 3rd. The shares were sold at an average price of $212.47, for a total transaction of $3,211,271.58. Following the completion of the sale, the senior vice president now owns 13,447 shares of the company’s stock, valued at approximately $2,857,084.09. The disclosure for this sale can be found here. In the last 90 days, insiders sold 46,381 shares of company stock valued at $9,893,347. Company insiders own 1.09% of the company’s stock.
Clorox stock opened at $203.05 on Friday. The stock has a market cap of $25.59 billion, a price-to-earnings ratio of 22.61, a price-to-earnings-growth ratio of 4.40 and a beta of 0.26. The company has a debt-to-equity ratio of 2.12, a current ratio of 1.41 and a quick ratio of 1.06. Clorox Co has a 1 year low of $144.31 and a 1 year high of $239.87. The firm has a 50-day moving average of $211.07 and a two-hundred day moving average of $214.95.
Clorox (NYSE:CLX) last released its quarterly earnings data on Saturday, November 7th. The company reported $3.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.32 by $0.90. The company had revenue of $1.92 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Clorox had a net margin of 16.14% and a return on equity of 132.72%. The firm’s quarterly revenue was up 27.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.59 EPS. Research analysts expect that Clorox Co will post 8.03 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Wednesday, January 27th will be issued a $1.11 dividend. The ex-dividend date of this dividend is Tuesday, January 26th. This represents a $4.44 annualized dividend and a dividend yield of 2.19%. Clorox’s dividend payout ratio is currently 60.33%.
A number of equities analysts recently commented on the stock. Smith Barney Citigroup dropped their price target on shares of Clorox from $245.00 to $238.00 in a research note on Tuesday, November 3rd. Citigroup lifted their price target on shares of Clorox from $206.00 to $246.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. DA Davidson lifted their price target on shares of Clorox from $263.00 to $268.00 and gave the stock a “buy” rating in a research note on Tuesday, November 3rd. Zacks Investment Research cut shares of Clorox from a “buy” rating to a “hold” rating and set a $249.00 price target for the company. in a research note on Thursday, August 6th. Finally, Morgan Stanley lifted their price target on shares of Clorox from $193.00 to $197.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 4th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $215.23.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.
Featured Article: How is a buy-side analyst different from a sell-side analyst?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.